The prognostic significance of distant metastasis free interval (DMFI) in BRAF mutant advanced melanoma patients treated with first line targeted therapy

Authors :: Helen Gogas
Dimitris Bafaloukos
K-M. Giati
Helena Linardou
A. Anastasopoulou
A. Laskarakis
A. Tarampikou
P. Diamantopoulos
Theodoros N. Sergentanis
Source :: Annals of Oncology. 28:v441
Publication Year :: 2017
Publisher :: Elsevier BV, 2017.

Subjects :: Oncology
medicine.medical_specialty
business.industry
First line
medicine.medical_treatment
Mutant
Distant metastasis
Hematology
Targeted therapy
Free interval
Internal medicine
medicine
business
Advanced melanoma

Full Text Access

Tools